Movement Alert|Vertex Pharmaceuticals Falls 3.1% in Regular Trading, Trading at $527.91

Market Focus
Sep 08

On September 8, Vertex Pharmaceuticals fell 3.1% in regular trading, trading at $527.91 USD/share, with Turnover of $39.125 million.

Within the Biotechnology sector where Vertex Pharmaceuticals belongs, individual stocks showed broad divergence. Among major names, Amgen down 7.52%, Ionis Pharmaceuticals down 7.56%, Moderna, Inc. down 3.13%, AbbVie down 1.58%, while PDS Biotechnology Corporation surged 176.68%. Large-cap biotech stocks were broadly under pressure, with Vertex Pharmaceuticals tracking the sector-wide weakness.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10